Wolverine Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,516
Closed -$48K 2648
2022
Q3
$48K Buy
+40,516
New +$63.2K ﹤0.01% 1610
2021
Q1
Sell
-8,213
Closed -$55.1K 2359
2020
Q4
$39K Hold
8,213
﹤0.01% 1372
2020
Q3
$47K Hold
8,213
﹤0.01% 1278
2020
Q2
$55K Sell
8,213
-236,500
-97% -$1.79M ﹤0.01% 1216
2020
Q1
$1.56M Buy
+244,713
New +$1.96M 0.02% 401
2019
Q1
Sell
-4,864
Closed -$122K 1788
2018
Q4
$87K Buy
4,864
+3,500
+257% +$71.5K ﹤0.01% 1373
2018
Q3
$40K Sell
1,364
-1,296
-49% -$50.2K ﹤0.01% 1364
2018
Q2
$120K Buy
2,660
+810
+44% +$39.4K ﹤0.01% 1170
2018
Q1
$97K Sell
1,850
-513
-22% -$29.9K ﹤0.01% 1228
2017
Q4
$160K Sell
2,363
-5,372
-69% -$376K ﹤0.01% 1102
2017
Q3
$637K Sell
7,735
-1,865
-19% -$148K 0.01% 780
2017
Q2
$898K Buy
+9,600
New +$587K 0.01% 638
2016
Q4
Sell
-10,584
Closed -$373K 1367
2016
Q3
$381K Hold
10,584
0.01% 746
2016
Q2
$145K Buy
+10,584
New +$155K ﹤0.01% 930

Other funds holding CLVS